Literature DB >> 18629637

Fluorocitrate, an inhibitor of glial metabolism, inhibits the up-regulation of NOS expression, activity and NO production in the spinal cord induced by formalin test in rats.

Xiao-Cai Sun1, Wei-Na Chen, Shu-Qin Li, Jin-Song Cai, Wen-Bin Li, Xiao-Hui Xian, Yu-Yan Hu, Min Zhang, Qing-Jun Li.   

Abstract

Previous experiments have suggested that nitric oxide plays an important role in nociceptive transmission in the spinal cord. In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of fluorocitrate (FC), an inhibitor of glial metabolism, on NOS expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats. Sixty adult male Sprague-Dawley rats were randomly assigned into sham, formalin, formalin + normal saline (NS), and formalin + FC groups. The NOS expression, NOS activity and NO production was detected by NADPH-d histochemistry staining, NOS and NO assay kit, respectively. It was found that formalin test significantly up-regulated NOS expression and activity and NO production in the laminae I-II of the dorsal horn and the grey matter around the central canal in the lumbar spinal cord at 1 h after the formalin test. Selective inhibition of glia metabolism with intrathecal administration of FC (1 nmol) significantly inhibited the up-regulation in NOS expression and activity and NO production normally induced by the formalin test, which was represented with decreases in the number and density of the NADPH-d positive cells in the dorsal horn and grey matter around the central canal, and decrease in density of NADPH-d positive neuropil in the dorsal horn in formalin + FC group compared with formalin group. The results suggested that glia may be involved in the NO-mediated nociceptive transmission in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18629637     DOI: 10.1007/s11064-008-9785-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  45 in total

Review 1.  Spinal cord glia: new players in pain.

Authors:  L R Watkins; E D Milligan; S F Maier
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

2.  Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120.

Authors:  Diana K Schoeniger-Skinner; Annemarie Ledeboer; Matthew G Frank; Erin D Milligan; Stephen Poole; David Martin; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2007-01-03       Impact factor: 7.217

3.  Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines.

Authors:  E D Milligan; K A O'Connor; K T Nguyen; C B Armstrong; C Twining; R P Gaykema; A Holguin; D Martin; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

4.  Microglial reactions after subcutaneous formalin injection into the rat hind paw.

Authors:  K Y Fu; A R Light; G K Matsushima; W Maixner
Journal:  Brain Res       Date:  1999-04-17       Impact factor: 3.252

5.  Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat.

Authors:  L R Watkins; D Martin; P Ulrich; K J Tracey; S F Maier
Journal:  Pain       Date:  1997-07       Impact factor: 6.961

6.  Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.

Authors:  Mei Feng; Lihua Liu; Zheng Guo; Yan Xiong
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

7.  Anatomical and physiological studies of the gray matter surrounding the spinal cord central canal.

Authors:  R L Nahin; A M Madsen; G J Giesler
Journal:  J Comp Neurol       Date:  1983-11-01       Impact factor: 3.215

8.  Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain.

Authors:  F Y Tanga; V Raghavendra; J A DeLeo
Journal:  Neurochem Int       Date:  2004 Jul-Aug       Impact factor: 3.921

9.  HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS).

Authors:  Adelina Holguin; Kevin A O'Connor; Joseph Biedenkapp; Jay Campisi; Julie Wieseler-Frank; Erin D Milligan; Michael K Hansen; Leah Spataro; Elena Maksimova; Courtenay Bravmann; David Martin; Monika Fleshner; Steven F Maier; Linda R Watkins
Journal:  Pain       Date:  2004-08       Impact factor: 6.961

10.  Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain.

Authors:  Wei Guo; Hu Wang; Mineo Watanabe; Kohei Shimizu; Shiping Zou; Stacey C LaGraize; Feng Wei; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

View more
  4 in total

Review 1.  Long-term control of neuropathic pain in a non-viral gene therapy paradigm.

Authors:  E M Sloane; R G Soderquist; S F Maier; M J Mahoney; L R Watkins; E D Milligan
Journal:  Gene Ther       Date:  2009-03-05       Impact factor: 5.250

2.  The analgesic effect and mechanism of the combination of sodium ferulate and oxymatrine.

Authors:  Hanqing Liu; Yan Sun; Yan Gao; Fangfang Chen; MingBo Xu; Zhifeng Liu
Journal:  Neurochem Res       Date:  2010-06-03       Impact factor: 3.996

3.  Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats.

Authors:  Changlong Zheng; Luyun Wang; Rui Li; Ben Ma; Ling Tu; Xizhen Xu; Ryan T Dackor; Darryl C Zeldin; Dao Wen Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-29       Impact factor: 6.914

4.  Flexibilide obtained from cultured soft coral has anti-neuroinflammatory and analgesic effects through the upregulation of spinal transforming growth factor-β1 in neuropathic rats.

Authors:  Nan-Fu Chen; Shi-Ying Huang; Ching-Hsiang Lu; Chun-Lin Chen; Chien-Wei Feng; Chun-Hong Chen; Han-Chun Hung; Yen-You Lin; Ping-Jyun Sung; Chun-Sung Sung; San-Nan Yang; Hui-Min David Wang; Yu-Chia Chang; Jyh-Horng Sheu; Wu-Fu Chen; Zhi-Hong Wen
Journal:  Mar Drugs       Date:  2014-06-27       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.